Bryan J. Goodwin

机构：Enanta Pharmaceuticals (United States) · ORCID：0000-0002-5908-8380

发表论文 83 篇 · 总被引 17612 次 · h-index 48

代表论文

• Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis (2005 · Cell Metabolism · 被引 1860)
• Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis (2003 · Genes & Development · 被引 695)
• A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects (2016 · Cell Metabolism · 被引 497)
• Identification of a Novel Human Constitutive Androstane Receptor (CAR) Agonist and Its Use in the Identification of CAR Target Genes (2003 · Journal of Biological Chemistry · 被引 420)
• Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis (2003 · Journal of Clinical Investigation · 被引 388)
• FGF21 Regulates Sweet and Alcohol Preference (2015 · Cell Metabolism · 被引 348)